Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications quantitative benefit risk tradeoff preferences crohns disease treatment implications
… Benefit-Risk Preferences Benefit-risk preference studies are a specific … positive net benefit from having access to the treatment. Quantitative estimates of maximum acceptable risk can help …
… Benefit-Risk Assessment Do your product’s benefits outweigh its … team to help you navigate the ever-evolving landscape of benefit-risk assessment and meet the requirements of … strategy Incorporating patient and/or provider preferences and patient perspectives Selecting the best …
… strike between treatment benefits and risks. MCDA provides quantitative information that can help you understand and communicate risk tolerance from patients and other stakeholders to inform … MCDA can also help catalog issues that could arise in benefit-risk assessments . Additionally, the decision process …
… can help patients evaluate the trade-off between clinical benefit and treatment toxicity to make informed treatment … the Q-TWiST method to quantitatively assess the benefit/risk tradeoff of your new treatment regimen. Healthcare Resource …
… you to fully understand the potential and positioning of a treatment in the market. Preference studies can be used to … and treatment effectiveness Critical satisfaction measures Risk management strategies Risk tolerance assessments Let our … you understand your patients’ (or other stakeholders’) preferences and predict how they value different treatment …
… to incorporate the perceived value of a given health benefit into decisions regarding allocation of health care … - Perform health state valuation studies using time-tradeoff and standard gamble - Capture utility data … such as NICE, SMC, CDR, and PBAC), value messaging , and publications A Team Approach Let our multidisciplinary team …
… group. However, some patients in your study will benefit more or less than the average. Who are they and can … geography, standards of care, or even expectations and preferences—for which your drug is highly effective. And the … for market segmentation - Provide evidence for possible risk-sharing plans for reimbursement Regulatory Approval - …
… address a safety issue of regulatory importance within a risk management plan Designing studies to evaluate the … plans to use in regulatory discussions Advising on benefit-risk assessment methods for specific products … as those to address issues of nonrandom assignment of drug treatment Providing training on epidemiology methods, …
… the safety of your patients by examining and understanding disease indicators and using real-world evidence to support … activities. To understand disease distribution, risk factors, treatment patterns and impact, comorbidities, …
… in a discrete-choice experiment are asked to choose among treatment options with different sets of benefits and … are relative based on a person’s understanding of their disease state, disease progression, and available therapies, so market …